Stay updated on Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer revision identifier updates from v3.7.2 to v3.8.0, while the page continues to display a 403 access error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-03T10:27:37.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer’s site revision indicator changed from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-20T09:49:12.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The clinical trial record is replaced by a 403 Forbidden message, so its study details are no longer displayed.
    Difference
    17%
    Check dated 2026-10-13T13:27:15.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page now displays the ClinicalTrials.gov record for a phase 2 study of nivolumab plus ipilimumab as neoadjuvant therapy for hepatocellular carcinoma. It includes the study’s design, eligibility requirements, locations, outcomes, and record dates.
    Difference
    48%
    Check dated 2026-10-06T13:55:20.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the full study record with an error page. This blocks access to the trial's content and navigational context, signaling an outage or restricted access.
    Difference
    17%
    Check dated 2026-09-22T21:49:52.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.7.0, replacing the previous Revision: v3.6.6, indicating a page version update. This is a maintenance update and does not change trial content or details.
    Difference
    0.1%
    Check dated 2026-09-15T21:39:29.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial page.